Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Split Body, Evaluator-blinded, Trial on the Effect of Tergase Injection (Berahyaluronidase Alfa) on Reducing Edema After Both Total Knee Arthroplasty

NCT07705165 is registered in ClinicalTrials.gov with Man Soo Kim as lead sponsor.

NCT NCT07705165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07705165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Split Body, Evaluator-blinded, Trial on the Effect of Tergase Injection (Berahyaluronidase Alfa) on Reducing Edema After Both Total Knee Arthroplasty
Lead sponsor
Man Soo Kim
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
March 31, 2028
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bilateral total knee arthroplasty, osteoarthritis, knee, postoperative edema